You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bladder Neoplasm

Showing 51 - 75 of 4,848
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Death Using Less Invasive Diagnostic Tests- Liquid

Unknown status
  • Neoplasm, Colorectal
  • +5 more
  • ctDNA blood sampling
  • Sutton, Surrey, United Kingdom
    Royal Marsden Hospital
Sep 25, 2020

Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma

Active, not recruiting
Has Results
  • Recurrent Malignant Solid Neoplasm
  • +15 more
  • Canady Helios Cold Plasma Scalpel
  • Washington, District of Columbia
    Canady Surgical Group PC
Jul 16, 2021

Bladder Cancer, Bladder Tumor, Bladder Tumors Trial in Hanover, New York, Philadelphia (Synergo® RITE + MMC)

Terminated
  • Bladder Cancer
  • +10 more
  • Synergo® RITE + MMC
  • Hanover, Maryland
  • +3 more
Apr 14, 2020

Advanced Solid Tumor, Metastatic Cancer, HER2-positive Breast Cancer Trial (SNK01, Trastuzumab, Cetuximab)

Withdrawn
  • Advanced Solid Tumor
  • +16 more
  • SNK01
  • +2 more
  • (no location specified)
May 10, 2021

Lung Cancer Metastatic, Renal Cell Carcinoma, Head Neck Cancer Trial in France (Reduced dose intensity of IO)

Recruiting
  • Lung Cancer Metastatic
  • +7 more
  • Reduced dose intensity of IO
  • Angers, France
  • +25 more
Jun 24, 2022

HER2-positive Breast Cancer, HER2 Low, SYD-985 Trial in Aurora (Vic-trastuzumab duocarmazine (SYD985) + paclitaxel)

Recruiting
  • HER2-positive Breast Cancer
  • +26 more
  • Vic-trastuzumab duocarmazine (SYD985) + paclitaxel
  • Aurora, Colorado
    University of Colorado Cancer Center
Oct 22, 2021

The Importance of Muscle Function in Disseminated Bladder Cancer

Unknown status
  • Urinary Bladder Neoplasm
  • Evaluation of muscle mass and muscle function
  • Copenhagen, Denmark
    Rigshospitalet
Nov 18, 2019

MRI Contrast Media Adverse Reaction, Bladder Cancer, Bladder Disease Trial in Mansoura (Multi-parametric MRI)

Unknown status
  • MRI Contrast Media Adverse Reaction
  • +6 more
  • Multi-parametric MRI
  • Mansoura, Aldakahlia, Egypt
    Urology and Nephrology Center
Nov 20, 2019

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

Bladder Cancer, Bladder Disease, Bladder Tumor Trial in Mansourah (MicroRNAs-155, Human telomerase reverse transcriptase)

Completed
  • Bladder Cancer
  • +3 more
  • MicroRNAs-155
  • Human telomerase reverse transcriptase
  • Mansourah, Aldakahlia, Egypt
    Urology and Nephrology Center
Nov 1, 2019

BPH, Intravesical Botox, ThuLEP Trial (Thulium Laser Enucleation of the Prostate (ThuLEP), Intravesical Botox injection)

Not yet recruiting
  • BPH
  • +4 more
  • Thulium Laser Enucleation of the Prostate (ThuLEP)
  • Intravesical Botox injection
  • (no location specified)
Jun 11, 2023

Cancer, Metastatic, Cancer, Cancer of Pancreas Trial in New York (Clinical Trial Matching)

Recruiting
  • Cancer, Metastatic
  • +42 more
  • Clinical Trial Matching
  • New York, New York
    Massive Bio, Inc
May 21, 2021

Bladder Cancer, Bladder Urothelial Carcinoma, Trauma Trial in Mansoura (Computed tomographic cystography)

Unknown status
  • Bladder Cancer
  • +7 more
  • Computed tomographic cystography
  • Mansoura, Aldakahlia, Egypt
    Urology and Nephrology Center
Oct 15, 2019

Invasive Bladder Cancer Trial in Assuit (mpMRI)

Recruiting
  • Invasive Bladder Cancer
  • mpMRI
  • Assuit, Egypt
    Assuit university
Mar 13, 2023

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Schistosoma Related Bladder Diseases.

Not yet recruiting
  • Schistosoma Haematobium
  • Immunohistochemistry staining,
  • microscopic examination of urine
  • Assiut, Egypt
    Assiut University Hospital
Jul 4, 2023

Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma Trial in Puerto Rico, United States

Recruiting
  • Bladder Adenocarcinoma
  • +45 more
  • Cabozantinib S-malate
  • +2 more
  • Birmingham, Alabama
  • +563 more
Aug 24, 2022

Carcinoma, Transitional Cell, Bladder Cancer, Bladder Tumor Trial in Worldwide (Pralatrexate Injection, Vitamin B12, Folic Acid)

Completed
Has Results
  • Carcinoma, Transitional Cell
  • +2 more
  • Pralatrexate Injection
  • +2 more
  • Tucson, Arizona
  • +18 more
Dec 10, 2019

Advanced Cancer, Metastatic Cancer, Biliary Tract Carcinoma Trial in Chiba, Tokyo (Merestinib, Cisplatin, Gemcitabine)

Completed
  • Advanced Cancer
  • +6 more
  • Chiba, Japan
  • +1 more
May 18, 2020

Fecal Incontinence, Low Anterior Resection Syndrome, Malignant Anal Tumor Trial in Houston, Sugar Land (procedure, other,

Recruiting
  • Fecal Incontinence
  • +19 more
  • Explantation
  • +5 more
  • Houston, Texas
  • +1 more
Aug 21, 2019

Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Mobile, Alabama
  • +7 more
Jan 24, 2023

Care of Urothelial Cancer Patient and Prospective Procurement of

Recruiting
  • Bladder Cancer
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Superficial Bladder Cancer Trial in United States (ADSTILADRIN)

    Active, not recruiting
    Has Results
    • Superficial Bladder Cancer
    • ADSTILADRIN
    • Gilbert, Arizona
    • +33 more
    Dec 2, 2022

    Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • CD123 targeted CAR-NK cells
    • Taiyuan, Shanxi, China
      Shanxi Bethune Hospital
    Aug 28, 2023

    Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

    Recruiting
    • Myeloproliferative Neoplasm
    • +7 more
      • Hong Kong, Hong Kong
        Department of Medicine, Queen Mary Hospital
      May 21, 2023